Literature DB >> 6192094

Inhibition of passive localized experimental allergic encephalomyelitis by interferon.

S L Abreu, J Tondreau, S Levine, R Sowinski.   

Abstract

Recently it has been reported that interferon (IFN) suppresses experimental allergic encephalomyelitis (EAE) in actively immunized Lewis rats. In the present study the effect of IFN on a localized form of passively transferred EAE has been investigated. Localization and acceleration of the disease was obtained by injection of EAE lymph node cells into rats which had, 3 days previously, been prepared with a thermal brain injury. Within 24 h of cell transfer perivenular lymphocytic infiltrates (EAE lesions) were observed in the brain. Administration of IFN (40,000 U/kg) right after EAE lymph node cell injection resulted in a significant reduction or elimination of EAE lesions. The possibility that IFN is acting exclusively on the afferent arc is eliminated, and the results suggest that IFN may be acting, although not solely, through modulations of components of the efferent arc. IFN was equally effective in suppressing EAE in adrenalectomized animals. This demonstrates that the immunosuppressive effects observed in this study are not due to endogenously produced corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192094     DOI: 10.1159/000234836

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  6 in total

Review 1.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

Review 2.  Interferon-beta therapy in multiple sclerosis: evidence for a clinically relevant dose response.

Authors:  D S Goodin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Effect of rat and beta-human interferons on hyperacute experimental allergic encephalomyelitis in rats.

Authors:  F Hertz; R Deghenghi
Journal:  Agents Actions       Date:  1985-07

Review 4.  Anti-inflammatory properties of Type I interferons.

Authors:  Alfons Billiau
Journal:  Antiviral Res       Date:  2006-04-04       Impact factor: 5.970

5.  A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance.

Authors:  Saba I Aqel; Xiaozhi Yang; Emma E Kraus; Jinhua Song; Marissa F Farinas; Erin Y Zhao; Wei Pei; Amy E Lovett-Racke; Michael K Racke; Chenglong Li; Yuhong Yang
Journal:  JCI Insight       Date:  2021-02-22

6.  Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis.

Authors:  L Jacobs; A M Salazar; R Herndon; P A Reese; A Freeman; R Josefowicz; A Cuetter; F Husain; W A Smith; R Ekes
Journal:  Lancet       Date:  1986 Dec 20-27       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.